Boundless Bio, Inc. (BOLD) vs Cingulate Inc. (CING)
A side-by-side comparison of Boundless Bio, Inc. and Cingulate Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BOLD
Boundless Bio, Inc.
$2.60HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
CING
Cingulate Inc.
$4.75HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
Total return — BOLD vs CING
growth of $100 · dividends reinvested · last 3yBOLD -81.8% (-43.3%/yr)CING -64.0% (-28.9%/yr)CING compounded faster over this window
BOLD CING
BOLD vs CING: by the numbers
- •CING is the larger company ($64M vs $58M market cap).
Metrics side by side
Valuation
| Metric | BOLD | CING |
|---|---|---|
| P/B ratio | 0.89 | 2.73 |
| EV / EBITDA | N/A | 0.21 |
Profitability
| Metric | BOLD | CING |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -58.99% | -122.71% |
| ROIC | -43.97% | -83.74% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.